Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01973192 · ClinicalTrials.gov registry record
Viral Pathogenesis of Early Cystic Fibrosis Lung Disease
A clinical trial, sponsored by Indiana University.
- Completed
- Registry status
- 65
- Enrollment target
NCT01973192: Completed study, sponsored by Indiana University.
NCT01973192 is a clinical trial that has completed, run by Indiana University. The registered enrollment target is 65 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01973192 has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- 65 participants
- Enrollment target
Study Summary
The purpose of this study is to test the hypothesis that early viral infections alter the bacterial flora and inflammatory profile in the airway and accelerate progression of pulmonary disease in infants with cystic fibrosis.
Primary Outcome
To determine the effect(s) of viral infections on the evolution of endobronchial bacterial infection and inflammation in CF infants.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2013-05 |
| Est. Completion | 2016-12-01 |
What the finished NCT01973192 record still lists
NCT01973192 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 65 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01973192 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01973192 about?
NCT01973192 is a clinical study titled "Viral Pathogenesis of Early Cystic Fibrosis Lung Disease". The purpose of this study is to test the hypothesis that early viral infections alter the bacterial flora and inflammatory profile in the airway and accelerate progression of pulmonary disease in infants with cystic fibrosis.
What is the current status of trial NCT01973192?
This trial is currently completed. The enrollment target is 65 participants. The study started on 2013-05. Estimated completion is 2016-12-01.
Who is sponsoring clinical trial NCT01973192?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03366116 · 65 participants · Phase 1
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
- NCT03603730 · 65 participants · NA
Vagal Nerve Stimulation for Functional Dyspepsia and Gastroparesis
- NCT03796559 · 65 participants · NA
Magseed Enabled Long-Term Localization of Axillary Lymph Nodes
- NCT03993106 · 65 participants · Phase 2
A Study of sEphB4-HSA in Kaposi Sarcoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia